PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients

BACKGROUND: Biomarkers that facilitate the prediction of disease recurrence in head and neck squamous cell carcinoma (HNSCC) may enable physicians to personalize treatment. In the current study, DNA promoter methylation of programmed cell death 1 (PDCD1, PD-1) was evaluated as a prognostic biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Goltz, Diane, Gevensleben, Heidrun, Dietrich, Joern, Schroeck, Friederike, de Vos, Luka, Droege, Freya, Kristiansen, Glen, Schroeck, Andreas, Landsberg, Jennifer, Bootz, Friedrich, Dietrich, Dimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522222/
https://www.ncbi.nlm.nih.gov/pubmed/28487502
http://dx.doi.org/10.18632/oncotarget.17354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522222/
https://www.ncbi.nlm.nih.gov/pubmed/28487502
http://dx.doi.org/10.18632/oncotarget.17354

Ejemplares similares